Identification and treatment of symptoms associated with inflammation in medically ill patients

Psychoneuroendocrinology

Volumn 33, Issue 1, 2008, Pages 18-29

  Dantzer, Robert ^a   Capuron, Lucile ^b   Irwin, Michael R ^c   Miller, Andrew H ^d   Ollat, Helene ^e   Hugh Perry, Victor ^f   Rousey, Sarah ^a   Yirmiya, Raz ^g  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b CNRS   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Assoc pour Neuro Psycho P   (France)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Acute phase protein; Animal models; Biologic marker; Brain; Depression; Fatigue; Inflammation; Neuroimaging; Proinflammatory cytokines; Symptom burden; Therapy

Indexed keywords

ADALIMUMAB; ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; CELECOXIB; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 4; REBOXETINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA;

BLOOD BRAIN BARRIER; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; ENCEPHALITIS; HUMAN; INFLAMMATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; REVIEW; SYMPTOMATOLOGY;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; CHRONIC DISEASE; HUMANS; INFLAMMATION; NEUROIMMUNOMODULATION;

EID: 37649004941     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2007.10.008     Document Type: Review

References (57)

1. Anthony D.C., Bolton S.J., Fearn S., and Perry V.H. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 120 Pt 3 (1997) 435-444
2. Banati R.B. Visualising microglial activation in vivo. Glia 40 (2002) 206-217
3. Banati R.B., Myers R., and Kreutzberg G.W. PK ('peripheral benzodiazepine')-binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia. J. Neurocytol. 26 (1997) 77-82
4. Bell M.D., and Perry V.H. Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammagen or during acute neuronal degeneration. J. Neurocytol. 24 (1995) 695-710
5. Block M.L., Zecca L., and Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8 (2007) 57-69
6. Borsello T., Clarke P.G., Hirt L., Vercelli A., Repici M., Schorderet D.F., Bogousslavsky J., and Bonny C. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med. 9 (2003) 1180-1186
7. Boutry S., Laurent S., Elst L.V., and Muller R.N. Specific E-selectin targeting with a superparamagnetic MRI contrast agent. Contrast Media Mol. Imaging 1 (2006) 15-22
8. Boven L.A., Van Meurs M., Van Zwam M., Wierenga-Wolf A., Hintzen R.Q., Boot R.G., Aerts J.M., Amor S., Nieuwenhuis E.E., and Laman J.D. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 129 (2006) 517-526
9. Bower J.E. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav. Immun. 7 (2007) 863-871
10. Browning L.M., Krebs J.D., and Jebb S.A. Discrimination ratio analysis of inflammatory markers: implications for the study of inflammation in chronic disease. Metabolism 53 (2004) 899-903
11. Capuron L., and Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav. Immun. 17 Suppl. 1 (2003) S119-S124
12. Capuron L., Gumnick J.F., Musselman D.L., Lawson D.H., Reemsnyder A., Nemeroff C.B., and Miller A.H. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26 (2002) 643-652
13. Cava F., Gonzalez C., Pascual M.J., Navajo J.A., and Gonzalez-Buitrago J.M. Biological variation of interleukin 6 (IL-6) and soluble interleukin 2 receptor (sIL2R) in serum of healthy individuals. Cytokine 12 (2000) 1423-1425
14. Craig A.D. Interoception: the sense of the physiological condition of the body. Curr. Opin. Neurobiol. 13 (2003) 500-505
15. Craig A.D. Human feelings: why are some more aware than others?. Trends Cogn. Sci. 8 (2004) 239-241
16. Craig A.D. Forebrain emotional asymmetry: a neuroanatomical basis?. Trends Cogn. Sci. 9 (2005) 566-571
17. Critchley H.D., Wiens S., Rotshtein P., Ohman A., and Dolan R.J. Neural systems supporting interoceptive awareness. Nat. Neurosci. 7 (2004) 189-195
18. Damasio A.R. Descartes' Error: Emotion, Reason, and the Human Brain (1994), Putnam, New York
19. Dantzer R. Cytokine, sickness behavior, and depression. Neurol. Clin. 24 (2006) 441-460
20. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., 2007. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci., accepted for publication.
21. Dimsdale J.E., Ancoli-Israel S., Ayalon L., Elsmore T.F., and Gruen W. Taking fatigue seriously, II: variability in fatigue levels in cancer patients. Psychosomatics 48 (2007) 247-252
22. Duman C.H., Schlesinger L., Kodama M., Russell D.S., and Duman R.S. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol. Psychiatry 61 (2007) 661-670
23. Fan R., Xu F., Previti M.L., Davis J., Grande A.M., Robinson J.K., and Van Nostrand W.E. Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J. Neurosci. 27 (2007) 3057-3063
24. Galea I., Bechmann I., and Perry V.H. What is immune privilege (not)?. Trends Immunol. 28 (2007) 12-18
25. Goshen, L., Kreisel, T., Ben-Menachem Zidon, O., Weidenfeld, J., Ben-Hur, T., Yirmiya, R., 2007. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol. Psychiatry, in press, doi:10.1038/sj.mp.4002055.
26. Grippo A.J., Francis J., Weiss R.M., Felder R.B., and Johnson A.K. Cytokine mediation of experimental heart failure-induced anhedonia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284 (2003) R666-R673
27. James W. What is an emotion?. Mind 9 (1884) 188-205
28. Koenig W. Cardiovascular biomarkers: added value with an integrated approach?. Circulation 116 (2007) 3-5
29. Lestage J., Verrier D., Palin K., and Dantzer R. The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav. Immun. 16 (2002) 596-601
30. Malemud C.J. Inhibitors of stress-activated protein/mitogen-activated protein kinase pathways. Curr. Opin. Pharmacol. 7 (2007) 339-343
31. May M.J., D'Acquisto F., Madge L.A., Glockner J., Pober J.S., and Ghosh S. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289 (2000) 1550-1554
32. McFarland H.F., Barkhof F., Antel J., and Miller D.H. The role of MRI as a surrogate outcome measure in multiple sclerosis. Multiple Scler. 8 (2002) 40-51
33. Monk J.P., Phillips G., Waite R., Kuhn J., Schaaf L.J., Otterson G.A., Guttridge D., Rhoades C., Shah M., Criswell T., Caligiuri M.A., and Villalona-Calero M.A. Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J. Clin. Oncol. 24 (2006) 1852-1859
34. Moreau M., Lestage J., Verrier D., Mormede C., Kelley K.W., Dantzer R., and Castanon N. Bacille Calmette-Guerin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice. J. Infect. Dis. 192 (2005) 537-544
35. Muller N., Schwarz M.J., Dehning S., Douhe A., Cerovecki A., Goldstein-Muller B., Spellmann I., Hetzel G., Maino K., Kleindienst N., Moller H.J., Arolt V., and Riedel M. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatry 11 (2006) 680-684
36. Nadjar A., Bluthe R.M., May M.J., Dantzer R., and Parnet P. Inactivation of the cerebral NFkappaB pathway inhibits interleukin-1beta-induced sickness behavior and c-Fos expression in various brain nuclei. Neuropsychopharmacology 30 (2005) 1492-1499
37. Ng A., Bursteinas B., Gao Q., Mollison E., and Zvelebil M. Resources for integrative systems biology: from data through databases to networks and dynamic system models. Brief. Bioinform. 7 (2006) 318-330
38. Perry V.H., Cunningham C., and Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 7 (2007) 161-167
39. Pollak Y., Gilboa A., Ben-Menachem O., Ben-Hur T., Soreq H., and Yirmiya R. Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production. Ann. Neurol. 57 (2005) 741-745
40. Raison C.L., Capuron L., and Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27 (2006) 24-31
41. Rao K.M., Pieper C.S., Currie M.S., and Cohen H.J. Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. Am. J. Clin. Pathol. 102 (1994) 802-805
42. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., and Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 58 (2001) 445-452
43. Reynolds P.R., Larkman D.J., Haskard D.O., Hajnal J.V., Kennea N.L., George A.J., and Edwards A.D. Detection of vascular expression of E-selectin in vivo with MR imaging. Radiology 241 (2006) 469-476
44. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 (2003) 363-369
45. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
46. Schmidt M.I., Duncan B.B., Sharrett A.R., Lindberg G., Savage P.J., Offenbacher S., Azambuja M.I., Tracy R.P., and Heiss G. Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): a cohort study. Lancet 353 (1999) 1649-1652
47. Schwarcz R. The kynurenine pathway of tryptophan degradation as a drug target. Curr. Opin. Pharmacol. 4 (2004) 12-17
48. Sibson N.R., Blamire A.M., Bernades-Silva M., Laurent S., Boutry S., Muller R.N., Styles P., and Anthony D.C. MRI detection of early endothelial activation in brain inflammation. Magn. Reson. Med. 51 (2004) 248-252
49. Smith A., Thomas M., Kent J., and Nicholson K. Effects of the common cold on mood and performance. Psychoneuroendocrinology 23 (1998) 733-739
50. Strle K., Broussard S.R., McCusker R.H., Shen W.H., LeCleir J.M., Johnson R.W., Freund G.G., Dantzer R., and Kelley K.W. C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts. Endocrinology 147 (2006) 4363-4373
51. Teeling J.L., Felton L.M., Deacon R.M., Cunningham C., Rawlins J.N., and Perry V.H. Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines. Brain Behav. Immun. 21 (2007) 836-850
52. Tournier M., Sorbara F., Gindre C., Swendsen J.D., and Verdoux H. Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical population. Psychiat. Res. 118 (2003) 1-8
53. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 117 (2007) 289-296
54. Tsirpanlis G., Bagos P., Ioannou D., Bleta A., Marinou I., Lagouranis A., Chatzipanagiotou S., and Nicolaou C. The variability and accurate assessment of microinflammation in haemodialysis patients. Nephrol. Dial. Transplant. 19 (2004) 150-157
55. Tyring S., Gottlieb A., Papp K., Gordon K., Leonardi C., Wang A., Lalla D., Woolley M., Jahreis A., Zitnik R., Cella D., and Krishnan R. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367 (2006) 29-35
56. Ward P.A., and Lentsch A.B. Endogenous regulation of the acute inflammatory response. Mol. Cell. Biochem. 234-235 (2002) 225-228
57. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkle R., Seligman D.A., and Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav. Immun. 15 (2001) 199-226